ImmuneOncia Therapeutics Inc is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company is principally engaged in the research and development of antibody-based cancer immunotherapy treatments.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
15/09/26	₩3,515.00	+29.94%	54,339
14/09/26	₩2,705.00	-1.81%	1,068,266
11/09/26	₩2,755.00	-3.16%	117,942
10/09/26	₩2,845.00	-1.22%	134,866
09/09/26	₩2,880.00	0.00%	68,078

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 15/09/2026			5-day change	1st Jan Change
3,515.00 ^KRW	+29.94%		+20.79%	-73.00%

02-06	ImmuneOncia Therapeutics to conduct capital increase of 120 billion won for operational funds	RE
02/06/25	Immuneoncia Therapeutics, Inc. Announces Interim Results from Phase 1B Clinical Trial of Next-Generation Cd47 Antibody 'Imc-002' At Asco 2025	CI

Market Cap	321B 236M 204M 193M 175M 328M 22.6B 330M 2.3B 886M 11.46B 885M 865M 36.55B	P/E 2024 *	-	P/E 2025	-33.4x
Enterprise Value	298B 218M 189M 179M 162M 304M 20.96B 306M 2.14B 822M 10.63B 821M 802M 33.89B	EV / Sales 2024 *	-	EV / Sales 2025	8,473x
Free-Float	46.23%	Yield 2024 *	-	Yield 2025	-

02-06	ImmuneOncia Therapeutics to conduct capital increase of 120 billion won for operational funds	RE
02/06/25	Immuneoncia Therapeutics, Inc. Announces Interim Results from Phase 1B Clinical Trial of Next-Generation Cd47 Antibody 'Imc-002' At Asco 2025	CI
12/05/25	ImmuneOncia Therapeutics, Inc. has completed an IPO in the amount of KRW 32.905735 billion.	CI

1 day	+29.94%
1 week	+20.79%
Current month	+17.17%
1 month	+7.16%
3 months	-16.71%
6 months	-60.51%
Current year	-73.00%

ImmuneOncia Therapeutics, Inc. Stock

Stocks

A424870

KR7424870004

Biotechnology & Medical Research

Valuation: ImmuneOncia Therapeutics, Inc.

Chart: ImmuneOncia Therapeutics, Inc.

Latest news: ImmuneOncia Therapeutics, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: ImmuneOncia Therapeutics, Inc.

Bio Therapeutic Drugs

Financials

Company Profile

Quotes

1 week	2,665	3,515
1 month	2,665	3,515
Current year	2,300	14,240
1 year	2,300	16,110
3 years	2,300	16,110
5 years	2,300	16,110
10 years	2,300	16,110

Manager	Title	Age	Since
Heung-Tae Kim CEO	Chief Executive Officer	70	21/07/2021
Dong-Hyun Yoon DFI	Director of Finance/CFO	55	26/12/2023
Seong-Yeong Lee CTO	Chief Tech/Sci/R&D Officer	51	-

Director	Title	Age	Since
Heung-Tae Kim BRD	Director/Board Member	70	21/07/2021
Dong-Hyun Yoon BRD	Director/Board Member	55	26/12/2023
Sun-Myeong Baek BRD	Director/Board Member	69	30/03/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMMUNEONCIA THERAPEUTICS, INC.	+29.94%	+20.79%	-41.32%	-	183M
WUXI APPTEC CO., LTD.	-1.38%	+2.23%	+48.54%	+100.96%	70.24B
ARGENX SE	-1.04%	-0.81%	+34.61%	+75.16%	62.63B
INSMED INCORPORATED	-4.29%	-3.98%	-16.22%	+350.66%	27.36B
WUXI BIOLOGICS (CAYMAN) INC.	+0.16%	+1.53%	+34.92%	+17.47%	25.71B
BIONTECH SE	-2.20%	-2.00%	-1.22%	-14.48%	24.83B
GENMAB A/S	+1.61%	+0.42%	+19.44%	-20.66%	19.52B
PHARMAESSENTIA CORPORATION	+1.26%	-9.06%	+165.21%	+308.08%	15.51B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-3.91%	-5.71%	-8.71%	+521.92%	14.66B
SUMMIT THERAPEUTICS INC.	-5.54%	+0.69%	-8.13%	+830.48%	14.69B
Average	+1.46%	+1.01%	+22.71%	+241.06%	27.53B
Weighted average by Cap.	-1.50%	-0.63%	+31.55%	+166.14%

	2024	2025
Net sales	655M 480K 416K 393K 356K 669K 46.08M 674K 4.7M 1.81M 23.36M 1.8M 1.76M 74.51M	111M 81.61K 70.69K 66.85K 60.52K 114K 7.83M 114K 798K 307K 3.97M 307K 300K 12.66M
Net income	-5.69B -4.17M -3.62M -3.42M -3.09M -5.81M -400M -5.85M -40.79M -15.69M -203M -15.68M -15.33M -647M	-27.36B -20.08M -17.39M -16.45M -14.89M -27.95M -1.93B -28.16M -196M -75.51M -977M -75.43M -73.76M -3.11B
Net Debt	-11.23B -8.24M -7.14M -6.75M -6.11M -11.47M -791M -11.56M -80.56M -30.99M -401M -30.96M -30.27M -1.28B	-23.37B -17.15M -14.85M -14.05M -12.72M -23.87M -1.65B -24.05M -168M -64.49M -834M -64.42M -62.99M -2.66B